Russian cross-industry agreement on advertising compliance

Earlier this month, the leading Russian professional associations in the pharmaceutical industry and communication services market, in the presence of Federal Antimonopoly Service (FAS) Russia, signed the “Recommendations on compliance with legislation on advertising of non-prescription medicines” in Moscow. It was developed in close cooperation with FAS Russia.

The Recommendations were initiated by the Association of International Pharmaceutical Manufacturers, the Association of European Businesses, the Association of the Russian Pharmaceutical Manufacturers, and the Union of Professional Pharmaceutical Organizations whose membership includes over 100 of the largest Russian and international pharmaceutical companies that manufacture, supply and distribute a wide range of modern medicines within the Russian Federation, and by the Russian Association of Communication Agencies, the National Advertising Alliance, and the International Confederation of Consumer Societies.

The proposal to develop such a document was supported by the FAS from the very beginning. It was later implemented in close partnership with the regulator. Legal support for the project was provided by the Bryan Cave Leighton Paisner law firm.